Global Lung Cancer Screening Market to Expand as Lung Cancer Becomes More Prevalent: Fortune Business Insights

(The Express Wire via Comtex)

The global “lung cancer screening market” is set to witness a robust growth period on account of the rising prevalence of lung cancer across the globe. The International Agency for Research on Cancer (IARC) states that lung cancer is the leading type of cancer, causing 1.8 million deaths in 2018. A study published in the World Cancer Research Journal reveals that by 2040, the number of people affected by lung cancer will increase to 3,610,896, with the incidence rate being greater in men than women. This trend is expected to continue in the foreseeable future as pollution levels rise, especially in developing countries. Higher pollution levels would cause greater emission of toxins, thereby fuelling the global lung cancer screening market growth during the forecast period.

The report provides market analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions and mergers, new product and service launches, agreements, partnerships, collaborations and joint ventures, research and development, and regional expansion of major participants involved in the market on a global and regional basis.

Request a Sample Copy of the Research Report:

Rapidly Rising Pollution Levels to Boost the Market

Industries and vehicles emit toxic gases such as carbon monoxide and particulate matter which have been classified as carcinogenic by the IARC. Carbon emitted from coal burning is also known to cause cancer. Therefore, rising pollution levels, especially in developing nations, represents excellent sales opportunities for lung cancer screening technologies, fuelling the global lung cancer screening market revenue.

Key Companies and Manufacturers Covered:

  • Illumina Inc.
  • Thermo Fisher Scientific
  • AstraZeneca
  • Hoffmann-Le Roche Ltd
  • Jansenn Pharmaceuticals, Inc.
  • Abbott
  • Agilent Technologies, Inc.

Key Features of Lung Cancer Screening Market Report:

  • Overview, Industry Life Cycle Analysis, Supply Chain Analysis
  • Size, Trends, Growth Drivers, Constraints, SWOT Analysis, Forecast Analysis
  • Competitive Landscapes: Market Share, Product Portfolio, New Product Launches, etc.
  • Market attractiveness and Associated Growth Opportunities
  • Strategic Growth Opportunities for the Existing and New Players
  • Key Success Factors

Large Smoking Population to Thrust the Market in North America Upwards

North America is expected to hold a dominant section of the global lung cancer screening market share, primarily owing to the large number of smokers in the region. Additionally, a rising geriatric population and strong healthcare infrastructure are the other important drivers for the market in North America. In Asia-Pacific, large scale tobacco consumption and increasing pollution and population levels will drive the market in the region.

Have Any Query? Ask Our Experts:

Segmentation of the Global Lung Cancer Screening Market:

By Cancer Type

  • Non-Small Cell Lung Cancer
  • Small Cell Lung Cancer
  • Others

By Diagnosis Type

  • Low-Dose Spiral CT Scan
  • Chest X-Ray
  • Sputum Cytology
  • Others

By End User

  • Hospitals
  • Oncology Clinics
  • Diagnostics Centers
  • Others

By Geography

  • North America (USA and Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico and Rest of Latin America)
  • Middle East and Africa (South Africa, GCC and Rest of the Middle East and Africa)

Reasons to Purchase this Report:

  • Detailed business profiles including product offerings, recent developments, key financial information, and strategies employed by main market players.
  • Analysis of various regions and countries that includes the demand and supply based actions, which consequently have a major influence on the market’s expansion.
  • Market dynamics and opportunities for growth for players in the near future.
  • Competitive landscape describing the market revenue shares of key players.
  • Market segmentation analysis that deals with quantitative and qualitative research, discussing the influence of policy-based and economical aspects.

Our proven methodologies and systematic analysis help in making confident business and strategic decisions.

A market study that conducts at Fortune Business Insights can save significant cost and time, and can help prevent making costly mistakes.

Order Full Report:

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune - 411045, Maharashtra, India.


US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email:[email protected]


Press Release Distributed by The Express Wire

To view the original version on The Express Wire visit Global Lung Cancer Screening Market to Expand as Lung Cancer Becomes More Prevalent: Fortune Business Insights

comtex tracking